MedPath

Comparing effect of sertaconazole 2% cream versus clotrimazole 1% cream on treatment of seborrheic dermatitis in adult

Phase 2
Conditions
Seborrheic dermatitis.
Seborrhoeic dermatitis, unspecified
Registration Number
IRCT201701299014N141
Lead Sponsor
Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
100
Inclusion Criteria

age of 18 to 65 years; seborrheic dermatitis the scalp and face area.
Exclusion criteria: pregnancy or breastfeeding; severe seborrheic dermatitis with Itching score greater than 7; treatment with local or systemic corticosteroid, methyldopa, chlorpromazine, or anti-acne drugs during the last month; systemic disease such as Parkinson, AIDS, and mood disorder; sensitivity to drug.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
umber and size of the wound. Timepoint: before and 4 weeks after intervention. Method of measurement: through clinical examination.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath